Search Results - "Wibroe, Peter P"

An integrated assessment of morphology, size, and complement activation of the PEGylated liposomal doxorubicin products Doxil®, Caelyx®, DOXOrubicin, and SinaDoxosome by Wibroe, Peter P., Ahmadvand, Davoud, Oghabian, Mohammad Ali, Yaghmur, Anan, Moghimi, S. Moein

“…In order to improve patient's benefit and safety, comprehensive regulatory guidelines on specificities of Non-Biological Complex Drugs (NBCDs), such as…”
Get full text

Material properties in complement activation by Moghimi, S. Moein, Andersen, Alina J., Ahmadvand, Davoud, Wibroe, Peter P., Andresen, Thomas L., Hunter, A. Christy

“…Uncontrolled complement activation can induce many inflammatory and life threatening conditions. Accordingly, the role of complement in initiation of adverse…”
Get full text

Citrem modulates internal nanostructure of glyceryl monooleate dispersions and bypasses complement activation: Towards development of safe tunable intravenous lipid nanocarriers by Wibroe, Peter P., MSc, Mat Azmi, Intan D., MSc, Nilsson, Christa, MSc, Yaghmur, Anan, PhD, Moghimi, S. Moein, PhD

“…Abstract Lyotropic non-lamellar liquid crystalline (LLC) aqueous nanodispersions hold a great promise in drug solubilization and delivery, but these…”
Get full text

A structurally diverse library of safe-by-design citrem-phospholipid lamellar and non-lamellar liquid crystalline nano-assemblies by Azmi, Intan D.M., Wibroe, Peter P., Wu, Lin-Ping, Kazem, Ali I., Amenitsch, Heinz, Moghimi, Seyed M., Yaghmur, Anan

“…Non-lamellar liquid crystalline aqueous nanodispersions, known also as ISAsomes (internally self-assembled ‘somes’ or nanoparticles), are gaining increasing…”
Get full text

Polymeric particulate technologies for oral drug delivery and targeting: a pathophysiological perspective by Hunter, A. Christy, Elsom, Jacqueline, Wibroe, Peter P, Moghimi, S. Moein

“…Abstract The oral route for delivery of pharmaceuticals is the most widely used and accepted. Nanoparticles and microparticles are increasingly being applied…”
Get full text

Perspectives on carbon nanotube-mediated adverse immune effects by Andersen, Alina J., Wibroe, Peter P., Moghimi, S. Moein

“…Carbon nanotubes are entities of different morphology and aspect ratios with anisotropic character. Due to their unique electronic, photonic, mechanical and…”
Get full text

Soluble and immobilized graphene oxide activates complement system differently dependent on surface oxidation state by Wibroe, Peter P, Petersen, Søren V, Bovet, Nicolas, Laursen, Bo W, Moghimi, S. Moein

“…Abstract Graphene oxide (GO) is believed to become applicable in biomedical products and medicine, thereby necessitating appropriate safety evaluation…”
Get full text

Polymeric particulate technologies for oral drug delivery and targeting: A pathophysiological perspective by Hunter, A. Christy, Elsom, Jacqueline, Wibroe, Peter P, Moghimi, S. Moein

“…Abstract The oral route for delivery of pharmaceuticals is the most widely used and accepted. Nanoparticles and microparticles are increasingly being applied…”
Get full text

Structural profiling and biological performance of phospholipid–hyaluronan functionalized single-walled carbon nanotubes by Dvash, Ram, Khatchatouriants, Artium, Solmesky, Leonardo J., Wibroe, Peter P., Weil, Miguel, Moghimi, S. Moein, Peer, Dan

“…In spite of significant insolubility and toxicity, carbon nanotubes (CNTs) erupt into the biomedical research, and create an increasing interest in the field…”
Get full text

Genomic perspectives in inter-individual adverse responses following nanomedicine administration: The way forward by Moghimi, S. Moein, Wibroe, Peter P., Helvig, Shen Y., Farhangrazi, Z. Shadi, Hunter, A. Christy

“…The underlying mechanism of intravenous infusion-related adverse reactions inherent to regulatory-approved nanomedicines still remains elusive. There are…”
Get full text

Surfactant-mediated complement activation in beagle dogs by Moghimi, S. Moein, Wibroe, Peter P., Szebeni, Janos, Hunter, A. Christy

Get full text

The Role of Complement in Antibody Therapy for Infectious Diseases by Wibroe, Peter P, Helvig, Shen Y, Moein Moghimi, S

“…The complement system is part of the innate immune system, eliciting central immunoregulatory functions. Detection of foreign surfaces is either achieved…”
Get more information

Perspectives on carbon nanotube-mediated adverse immune effects: Nanotoxicity: From Bench to Bedside by ANDERSEN, Alina J, WIBROE, Peter P, MOEIN MOGHIMI, S

Get full text

Genomic perspectives in inter-individual adverse responses following nanomedicine administration: The way forward: Personalized Nanomedicine by MOEIN MOGHIMI, S, WIBROE, Peter P, HELVIG, Shen Y, SHADI FARHANGRAZI, Z, CHRISTY HUNTER, A

Get full text

Static and Dynamic Disorder Observed in the Phase Transition Behavior of Individual Small Unilamellar Vesicles by Stamou, Dimitrios G., Bendix, Poul Martin, Wibroe, Peter P., Hatzakis, Nikos S.

Get full text

Phase Transitions in Single Nano-Vesicles by Bendix, Poul M., Wibroe, Peter P., Stamou, Dimitrios

Get full text

Polymeric particulate technologies for oral drug delivery and targeting: A pathophysiological perspective: Nanotechnology: From Fundamental Concepts to Clinical Applications for Healthy Aging by HUNTER, A. Christy, ELSOM, Jacqueline, WIBROE, Peter P, MOEIN MOGHIMI, S

Get full text

Material properties in complement activation: Complement Monitoring of Nanomedicines and Implants by MOEIN MOGHIMI, S, ANDERSEN, Alina J, AHMADVAND, Davoud, WIBROE, Peter P, ANDRESEN, Thomas L, CHRISTY HUNTER, A

Get full text